Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 GeneAzam Ghafoor, Raffit Hassan, Anish Thomas et al.|JTO Clinical and Research Reports|2021Cited by 57
Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesotheliomaNishanth Ulhas Nair, Raffit Hassan, Qun Jiang et al.|Cell Reports Medicine|2023Cited by 27
Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.Raffit Hassan, Azam Ghafoor, Idrees Mian et al.|Journal of Clinical Oncology|2020Cited by 22
Transcriptomics based prediction of survival and response to therapy in malignant mesotheliomaNishanth Ulhas Nair, Raffit Hassan, Qun Jiang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1